Press Releases

    • AUG 06 2018

    Clinical Cancer Research Article Describes Opportunity to Use Imipridones for Brain Tumors

    Philadelphia, PA (July 31, 2018) – Oncoceutics, Inc. announced the publication of a scientific research article in the journal Clinical Cancer Research that demonstrates utility for the company’s imipridone portfolio of compounds in neuro-oncology. Oncoceutics developed this portfolio of chemical compounds that target G protein-coupled receptors (GPCRs) using the unique core chemical structure of the

    • MAY 29 2018

    Oncoceutics Abstracts at ASCO Highlight Efficacy of ONC201 in High-Grade Gliomas

    Philadelphia, PA (May 29, 2018) – Oncoceutics, Inc. announced that two abstracts will be presented at the 2018 Annual Meeting of the American Society of Clinical Oncology (ASCO) that will highlight clinical success of the company’s lead compound in treating high-grade gliomas (HGG), including those that harbor the H3 K27M mutation. The first abstract, entitled